Miltz, A. R. http://orcid.org/0000-0003-2771-7880
,
Rodger, A. J.
Lepri, A. Cozzi
Sewell, J.
Nwokolo, N. C.
Allan, S.
Scott, C.
Ivens, D.
Lascar, M.
Speakman, A.
Phillips, A. N.
Sherr, L.
Collins, S.
Elford, J.
Lampe, F. C.
Funding for this research was provided by:
National Institute for Health Research (RP-PG-0608-10142)
Article History
First Online: 28 November 2019
Compliance with Ethical Standards
:
: ANP has received payments for presentations made at meetings sponsored by Gilead in spring 2015. NCN has received support for attendance at conferences, speaker fees and payments for attendance at advisory boards from Gilead Sciences, Viiv Healthcare, Janssen Pharmaceuticals and Bristol Myers Squibb and a research grant from Gilead Sciences.
: The research protocol and all versions of the study documents (information sheet, consent form, questionnaires and insert) were approved by the designated research ethics committee (NRES Committee London-Hampstead, ref: 13/LO/0246). Based on these documents, the study subsequently received permission for clinical research at all participating National Health Service sites.